Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients

Polaprezinc (PZ), an antiulcer drug, has been reported to have antioxidant properties. The aim of the present study was to assess the feasibility and efficacy of administering PZ for radiation-induced mucositis in head and neck cancer patients. Patients with newly diagnosed head and neck cancer were...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Clin Oncol
Egile Nagusiak: DOI, HIROSHI, FUJIWARA, MASAYUKI, SUZUKI, HITOMI, NIWA, YASUE, NAKAYAMA, MASAHIRO, SHIKATA, TOSHIYUKI, ODAWARA, SOICHI, TAKADA, YASUHIRO, KIMURA, TAKESHI, KAMIKONYA, NORIHIKO, HIROTA, SHOZO
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2015
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4360858/
https://ncbi.nlm.nih.gov/pubmed/25798271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.479
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak